| |
| |
|
| Insider
Information: |
Oboyle Kevin C |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
267,712 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$543,963 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
267,712 |
|
|
| Total
Value |
$543,963 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 36.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvasive Inc |
NUVA |
CFO and Executive VP |
2009-12-15 |
3,338 |
|
0 |
Premium* |
|
|
Wright Medical Group N.V |
WMGI |
Director |
2020-11-11 |
0 |
2011-05-12 |
0 |
Premium* |
|
|
Genmark Diagnostics, Inc. |
GNMK |
Director |
2021-04-22 |
0 |
2012-06-06 |
0 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
Director |
2014-11-17 |
0 |
2012-07-19 |
0 |
Premium* |
|
|
Zeltiq Aesthetics Inc |
ZLTQ |
Director |
2017-04-28 |
0 |
2014-03-04 |
0 |
Premium* |
|
|
Sientra, Inc. |
SIEN |
Director |
2022-06-09 |
220,978 |
2016-06-23 |
0 |
Premium* |
|
|
Nevro Corp |
NVRO |
|
2024-05-23 |
43,396 |
2019-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
215 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,998 |
121,548 |
0 |
- |
|
| SIEN |
Sientra, Inc. |
Director |
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
27,717 |
100,802 |
0 |
- |
|
| WMGI |
Wright Medical Group N.V |
Director |
– • – |
2020-11-11 |
4 |
D |
$30.75 |
$501,410 |
D/D |
(16,306) |
0 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,130 |
131,678 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2021-04-22 |
4 |
D |
$24.05 |
$3,166,856 |
D/D |
(131,678) |
0 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,167 |
10,918 |
0 |
- |
|
| SIEN |
Sientra, Inc. |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,870 |
117,672 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2021-12-14 |
4 |
B |
$83.75 |
$201,070 |
D/D |
2,400 |
13,318 |
2.39 |
% |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,155 |
17,473 |
0 |
- |
|
| SIEN |
Sientra, Inc. |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
103,306 |
220,978 |
0 |
- |
|
| NVRO |
Nevro Corp |
|
• • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,754 |
24,227 |
0 |
- |
|
| NVRO |
Nevro Corp |
|
• • – |
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
19,169 |
43,396 |
0 |
- |
|
| NUVA |
Nuvasive Inc |
CFO and Executive VP |
• – – |
2009-09-14 |
4/A |
D |
$42.29 |
$109,869 |
D/D |
(2,598) |
6,740 |
0 |
- |
|
| NUVA |
Nuvasive Inc |
CFO and Executive VP |
• – – |
2009-09-15 |
4/A |
AS |
$42.25 |
$143,748 |
D/D |
(3,402) |
3,338 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Director |
– • – |
2012-07-19 |
5 |
B |
$9.00 |
$45,000 |
D/D |
5,000 |
5,000 |
0 |
- |
|
215 Records found
|
|
Page 9 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
